This paper analyzes some of the perverse incentives that may arise under the current Medicare prescription drug benefit design. In particular. risk adjustment for a standalone prescription drug benefit creates perverse incentives for prescription drug plans when making coverage decisions and/or for pharmaceutical companies when setting prices. This problem is new in that it does not a... https://cosmeticssquadets.shop/product-category/ear-putty/